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Abstract
Background: The TetR family member AmtR is the central regulator of nitrogen starvation
response in Corynebacterium glutamicum. While the AmtR regulon was physiologically characterized
in great detail up to now, mechanistic questions of AmtR binding were not addressed. This study
presents a characterization of functionally important amino acids in the DNA binding domain of
AmtR and of crucial nucleotides in the AmtR recognition motif.
Results: Site-directed mutagenesis, the characterization of corresponding mutant proteins by gel
retardation assays and surface plasmon resonance and molecular modelling revealed several amino
acids, which are directly involved in DNA binding, while others have more structural function.
Furthermore, we could show that the spacing of the binding motif half sites is crucial for repression
of transcription by AmtR.
Conclusion: Although the DNA binding domain of TetR-type repressors is highly conserved and
a core binding motif was identified for AmtR and TetR(D), the AmtR binding domain shows
individual properties compared to other TetR proteins. Besides by distinct amino acids of AmtR,
DNA binding is influenced by nucleotides not only of the conserved binding motif but also by
spacing nucleotides in C. glutamicum.
Background
Almost all of the macromolecules in a bacterial cell, e.g.
proteins, nucleic acids and cell wall components, contain
nitrogen. Thus, prokaryotes have developed elaborate
mechanisms to provide an optimal nitrogen supply for
metabolism and to overcome and survive situations of
nitrogen limitation, generally summarized as nitrogen
control. This communication focuses on nitrogen control
in Corynebacterium glutamicum, a Gram-positive soil bacte-
rium used for the industrial production of amino acids
[1]. We have been studying nitrogen metabolism and
nitrogen regulation in corynebacteria with a focus on C.
glutamicum for several years (for recent reviews, see [2-4])
and could show that transcription of genes in response to
nitrogen limitation is governed in corynebacteria, i.e. C.
glutamicum, Corynebacterium efficiens and Corynebacterium
diphtheriae, by TetR-type regulator AmtR [5,6], which
blocks transcription of various genes during growth in
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nitrogen-rich medium. The AmtR regulon of C. glutami-
cum was characterized by a combination of bioinformat-
ics and molecular biology approaches. At least 35 genes,
which encode transporters and enzymes for ammonium
assimilation (amtA, amtB, glnA, gltBD, dapD), creatinine
(codA, crnT) and urea metabolism (urtABCDE, ureABCE-
FGD), a number of biochemically uncharacterized
enzymes and transport systems as well as signal transduc-
tion proteins (glnD, glnK), are directly controlled by the
AmtR protein in C. glutamicum [7,8].
An AmtR binding site consensus motif was deduced from
bioinformatic analyses of available genome sequence
information and competitive gel retardation assays [7,8].
The resulting AmtR box with the nucleotide sequence
tttCTATN6AtAGat/aA (with bases represented by capital
letters being highly conserved) is a more or less palindro-
mic sequence and can be located in the promoter region
either on the sense or antisense strand.
In this study we address the question which amino acids
within the AmtR DNA binding domain are in fact contact-
ing the DNA and why AmtR expression is not controlled
by an autoregulatory circuit as found for other TetR-type
regulators (for review, see [9])
Results
Characterization of the AmtR binding domain reveals 
functionally important amino acid residues
As a molecular biology approach to identify amino acid
residues of AmtR involved in DNA binding, site-directed
mutagenesis experiments were carried out. Amino acids
highly conserved in the DNA binding domain of TetR
family proteins (Fig. 1) were selected and exchanged
against alanine, with exception of the conserved Ala54
residue, which was changed to glycine. Wild type AmtR
and AmtR variants were purified as maltose binding pro-
tein (MBP) fusions and applied in gel retardation experi-
ments. As target sequence a PCR fragment spanning
nucleotides -298 to -1 relative to the start codon of the
amtB gene and comprising three AmtR binding sites [4,7]
was used. While 150 ng of wild type AmtR-MBP led to a
complete retardation of 0.04 ng of target DNA, the same
amount of MBP had no effect (Fig. 2A). Subsequently car-
ried out gel retardation experiments with rising amounts
of AmtR variants (addition of AmtR*-MBP up to 3 μg)
revealed that exchange of residues Glu23, Thr33, Gly36
and Thr42 had no effect. The corresponding recombinant
proteins behaved as wild type. A slightly reduced affinity
compared to wild type AmtR was observed for AmtR*
with exchange of His43 and Arg52 to alanine and Ala54
to glycine, while significantly reduced binding was
observed for alterations of Glu30, Leu31, Thr40, Gly50,
Gln53, Ser55, Tyr57, Tyr58 and Leu71. Mutations result-
ing in an alanine exchange at positions Phe32, Ile51,
Leu56, His59 and Leu70 led to a complete loss of AmtR*
binding (Fig. 2B).
From these gel retardation assays, KD values for the bind-
ing of AmtR-MBP and selected AmtR*-MBP variants were
estimated. The equilibrium binding constant for AmtR-
MBP was 2.4 × 10-6 M and 2.2 × 10-6 M for the variant car-
Sequence alignment of AmtR proteins from different Gram-positive bacteria Figure 1
Sequence alignment of AmtR proteins from different Gram-positive bacteria. Amino acid residues identical in all 
sequences are shaded in black, other conserved amino acids in gray.
C. glutamicum 1 --------MAGA-VGRPRRSAPRRAGKNPREEILDASAELFTRQGFATTSTHQIADAVGIRQASLYYHFPSKTEIFLTLLKSTVEPSTVL
C. efficiens 1 --------MAGA-VGRPRRSAPRRAGKNPREEILDASAELFTRQGFATTSTHQIADAVGIRQASLYYHFPSKTEIFLTLLKSTVEPSMVL
C. diphtheriae 1 --------MAGA-VGRPRKNSPRRRGSTAREEILDASAELFTTQGFATTSTHQIADAVGIRQASLYYHFPSKTEIFLTLLQSTVAPSTAL
S. avermitilis 1 ------MGTSGRRVGRPRAAQRPDSGLSPRDELLTAAAELFTTRGYAATTTRAVAERAGMRQASMYHYVSGKEELLAALLESTVTPSLAL
M. smegmatis 1 -----MTTTSGR--GRPRLEQPRRPGQTAREEILDAAAELFTTHGYGSTSTRRIADEVGVRQASLYHHFATKDDILDALLAGTVDEPLEL
N. farcinica 1 MRQNGEVTSLGP--GRPRLAPRRRQGRTPRAEILDAAAELFTTQGYASTSTRAVADAVGIRQASLYHHFAAKDDILEALLAETVSGPLAL
A. aurescens 1 ------MTTAGP--GRPRKQQAVRPGATARDEILDAAAELFTGQGFANTSTRAIADAVGIRQSSLYHHFSTKDEILGELLGGTVSTSLDF
Rhodococcus sp. 1 -------MTTGP--GRPRLTSQRRPGQTTPEEILDAAGELFTTKGFAATSTRQIAEMVGIRQASLYHHFPNKEEILAALLEETVSPALAA
C. glutamicum 82 AEDLS---TLDAGPEMRLWAIVASEVRLLLSTKWNVGRLYQLPIVGSEEFAEYHSQREALTNVFRDLATEIVG---------DDPRAELP
C. efficiens 82 AGDLA---NLEASPELRLWALVAAEVRLLLSTKWNVGRLYQLPIVASEEFEEYHTQRATLTDTFRSLATEIVGE--------DDPRAELP
C. diphtheriae 82 AEAFA---DNEAPAALRLWALTATECRLLLSTRWNVGRLYQLPVAASAEFASYQTQRDQLRQTFKNIASEILNP--------DDPRTDLP
S. avermitilis 85 ARHLLA--EDAAPAESRLWELCRTDVELLCGGPHNLGGLYLLPEVHTERFAGFHAVRAELKDTYRQLLAATAVGGALAKS-ELDLRTDLV
M. smegmatis 84 AHGLL---GESGPAAPRLHALVIYDASQLCAGRWNLGALYLLPELRTDRFAPFRRRRAELRSAYRSLAAAVIAECGGP----PE-ADDLP
N. farcinica 89 AERLR---AEPVAPAVRLYALARFDVRQLCSARWNLGALYLLPELRSARFAAFRRQRDDLRGHYERFAAEVLAAARAAH---AEGAELLP
A. aurescens 83 ARAIRQHSADAVSAAARLHAVVLFDGSQLCNSRWNLGVLYHLPEARAEIFQPFMAARKELRTIYSELGRELARVSDAD-----QGLGDTA
Rhodococcus sp. 82 AGRLA---DAAAPATVRLHALATYDVTQLTATKWNLGALYLLPELLTDRFEPFRAQRTLLRRHYRQLADQALTEITDDSGDTSPALTDLP
C. glutamicum 160 FHITMSVIEMRRNDGKIPSPLSADSLPETAIMLADASLAVLGAPLPADRVEKTLELIKQADAK------------
C. efficiens 161 FHITMSAIEMRRNDGKVPSPLSEDSLPDTAVMLADAALAVLGADLPGDRVERTLELLRQADAK------------
C. diphtheriae 161 FHIALSVIEMRSNDGVVPEPLRDDELPVLAIMLADAALAVVGAELPDDRVEWTLNLIRTLND-------------
S. avermitilis 172 FGLIEGVILVHRSDP--ERPVSAF-----AEATADAALRIVGV--------------------------------
M. smegmatis 166 FRLVESVINSRSDD----AVVPPE----QPWVIGEGALRVLGFDGDFAELAAATASRLGVRPPGRAAR-------
N. farcinica 173 FRMVESVINMRSDE----GTAPDY----AERLIPEAILHLLGHHDALGAVRAAADDLLD-RLDG-----------
A. aurescens 168 FRLVESLINLRAD-----GLISTD----SASTTADTVMILAGLKRELPAVRTASRDLIS-RFGDVPERVSSMKSA
Rhodococcus sp. 169 FRIVESAIATRADIE--RGLLPGPENEGAAGLLADACLRALGWTKPMDEIRAKSRALLAETAGGTPLRL------BMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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rying the Thr33Ala exchange, which is in accordance with
the wild type-like behaviour of this protein in the gel
retardation assay. With rising effect on binding, increasing
KD values were estimated, e. g. 1.0 and 2.0 × 10-5 M for
exchange Glu30 and Leu71, as well as 7.1 × 10-5 M for
AmtR*-MBP carrying the Ser55Ala exchange.
As an independent assay, surface plasmon resonance
(SPR) measurements were carried out. In these experi-
ments, the same AmtR-MBP preparations as in the gel
retardation assays were used, while the DNA immobilized
on the chip surface corresponded to a shorter fragment of
the amtB promoter resembling only one AmtR binding
site (nucleotide position -186 to -156, [4]). Again, puri-
fied maltose binding protein was used as negative control
and AmtR-MBP as positive control (Fig. 3A). MBP did not
bind to the immobilized DNA, while addition of AmtR-
MBP resulted in a clearly dose-dependent increase in
response units, indicating binding of the protein to its tar-
get DNA. Similarly, binding of AmtR variants was tested
(Fig. 3B). In general, results obtained with this approach
were similar to that described above for the gel retardation
assays. However, for exchange of Thr42, Ser55, Tyr57 and
Tyr58 a stronger reduction of binding was observed,
which might indicate a stabilization effect or cooperative
binding of AmtR-MBP, when more than one binding site
is available.
In summary, the analysis of AmtR variants generated by
site-directed mutagenesis and analyzed by gel retardation
experiments and SPR measurements hint to a crucial role
of several amino acids in DNA binding. However, it was
difficult to differ between direct and indirect effects.
Therefore, modelling experiments were carried out.
Molecular modelling indicates the function of distinct 
amino acids
In order to allow a structural interpretation of the AmtR
mutation data, we started a molecular modeling approach
of AmtR in complex with DNA based on the crystal struc-
ture of the TetR-DNA complex. The significant sequence
identity between the DNA-binding domains of the pro-
teins and the fact that they recognize an identical "CTAT"
core motif allowed the calculation of a molecular model
(Fig. 4), which provides the basis for subsequent detailed
analysis.
The model shares the same characteristic structural prop-
erties previously reported for the TetR-DNA crystal struc-
ture: The DNA-binding domains are constituted of helices
α1 to α4 of the N-terminal domains. The binding motif
itself consists of the α2-α3 loops (amino acid residues
Thr42 to His59) organized in helix-turn-helix (HTH)
motifs whereas helix 4 constitutes the link between the N-
Gelretardation assays using AmtR variants Figure 2
Gelretardation assays using AmtR variants. (A) A 
DNA fragment spanning nucleotides -298 to -1 relative to 
the start codon of amtB (0.04 ng DNA per lane) was used for 
the gel shift assay (1) negative control: 50 ng (2170 nM) of 
MBP, (2) 150 ng (2170 nM) wild type AmtR fused to MBP, (3) 
amtB upstream DNA without added protein. (B) Recom-
binant AmtR-MBP proteins carrying alanine exchanges of the 
indicated amino acid residues (with exception of Ala54, 
which was altered to glycine). DNA as described above plus 
(1) 0 ng, (2) 150 ng, (3) 750 ng, (4) 1950 ng, (5) 3 μg of the 
indicated AmtR*-MBP fusion.BMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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Surface plasmon resonance measurements Figure 3
Surface plasmon resonance measurements. An amtB promoter fragment spanning nucleotides -186 to -156 (relative to 
the start codon) was immobilized on Biacore chips rising concentrations of protein were added (for colour code, see Fig. 3A). 
(A) Binding properties of negative control (MBP) and positive control (AmtR-MBP fusion), (B) Influence of amino acid 
exchanges on binding of AmtR variants. Colour code for the concentrations of proteins added as in (A).
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and C-terminal domains. Each HTH motif of the repressor
binds to one major groove of the palindromic DNA con-
sensus nucleotide sequence "CTAT". Due to this twofold
symmetry, subsequent bioinformatic analysis was
restricted to one half-site of the complex.
The AmtR-DNA model complex reveals that 9 of the 21
residues investigated are in contact with the DNA while
the remaining 12 residues are located within the HTH
binding motif but do not directly bind DNA (Fig. 4; Table
1). These two groups were termed interface (IF) and non-
interface (NI) residues and their functions are discussed
separately below. For several non-interface residues
(Glu23, Thr33, Gly36), replacement by alanine had no
effect on DNA binding properties. Structural analysis
reveals that these residues are solvent exposed and do not
form crucial interactions within AmtR (Fig. 5a).
A completely different situation is present for those non-
interface residues, for which replacement by alanine leads
to a complete loss of DNA binding (Phe32, Ile51, Leu56,
Leu70). These residues are buried within the interior of
the protein and form interactions that stabilize the tertiary
structure of the HTH motif (Table 1; Fig. 5A, B). The
respective interactions cannot be formed by alanine in the
mutant protein structures, which will lead to a disruption
of the three-dimensional structure of the binding
domains consequently resulting in a (complete) loss of
DNA binding activity.
For the remaining group of non-interface residues (Glu30,
Leu31, Thr40, Gly50, Leu71), mutation results in weaker
DNA binding. These residues are either buried in the pro-
tein structure (Leu31, Thr40, Leu71), or involved in the
formation of a tight turn (Gly50) or a salt-bridge (Glu30).
A replacement by alanine is therefore expected to have at
least a moderate destabilizing effect for all of these
sequence positions. The mechanism, by which this desta-
bilization will reduce DNA binding affinity, cannot
unambiguously be determined from the static model
structure. One might speculate that mutation either leads
to rearrangements within AmtR or that mutation might
increase the portion of unfolded HTH domains, which are
no longer capable of DNA binding. The observation that
mutations can affect the disorder-order equilibrium of
proteins has been recently also described for a mutation
within the DNA binding domain of TetR as well [10].
The nine interface residues investigated can be divided
into those, which have no or moderate effects on binding
affinity (Thr42, His43, Arg52, Ala54) and those which
have a strong effect (Gln53, Ser55, Tyr57, Tyr58, His59).
The first group of residues generally forms only weak
interactions with the DNA (Table 1; Fig. 5C, D), while
Gln53, Ser55, and Tyr57 form tight contacts with the
"CTAT"-motif (Table 1; Fig. 5E). Gln53 for example spe-
cifically recognizes the purine ring of A4 via two hydrogen
bonds.
A special situation is observed for residues Tyr58 and
His59, which form only weak contacts with the DNA, but
nevertheless have a strong effect on binding affinity when
mutated to alanine: Tyr58 forms only weak interactions
with the ring of a non-conserved nucleotide at promoter
position -8 that is located adjacent to the "CTAT"-motif
(Fig. 5F). Tyr58, however, might play an additional role
for stabilizing the HTH motif by interaction with His59.
The side chain orientation of His59 appears to be particu-
larly important, since this residue forms both a hydrogen
bond with Asn19 at the N-terminus of helix α1, as well as
a water-mediated interaction with a phosphoryl group
Homology model of the AmtR repressor-operator complex Figure 4
Homology model of the AmtR repressor-operator 
complex. (A) Three-dimensional model of AmtR DNA 
binding domain in complex with DNA. The two binding sites 
of dimeric AmtR are shown separately on the left and right 
half of the picture. The protein is depicted in backbone pres-
entation and sequence positions that were experimentally 
investigated are shown as balls. The DNA backbone is shown 
as grey ribbon and the bases are colored according to their 
type. (B) Sequence of the AmtR operator indicating the 
numbering scheme used in the present work. The bases of 
the conserved "CTAT" recognition motif are explicitly 
labeled, while the remaining nonconserved bases are 
denoted as "N".BMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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(Fig. 5F) that was deduced in analogy to the TetR crystal
structure. Mutation of His59 to alanine might therefore
affect DNA binding both by direct and by indirect effects
thereby explaining the strong influence of this mutation.
The lack of AmtR autoregulation is caused by variations of 
spacing nucleotides rather than variation of the core 
binding motif
Compared to other TetR family members, C. glutamicum
AmtR lacks an autoregulation circuit (for review, see [9]).
Neither with DNA microarrays nor with real-time reverse
transcriptase PCR an upregulation of amtR  expression
upon nitrogen starvation was detectable in different stud-
ies [7,8,11-13], although an AmtR consensus site was
identified upstream of the amtR gene [5]. The reason for
the lack of autoregulation was unclear until now, how-
ever, compared to other AmtR binding sites the amtR
upstream sequence differs in two points (i) the presence
of a G instead of T at position 2 of the core motif and (ii)
in the number of spacing nucleotides between the two
half sites, 3 instead of 4. To investigate the importance of
these differences, gel shift experiments were carried out
using AmtR-MBP, wild type and modified amtR promoter
regions (Fig. 6). While a G to T nucleotide exchange at
position 2 had no significant effect, the introduction of an
additional nucleotide clearly led to the binding of AmtR-
MBP.
Discussion
TetR-type regulators are widely distributed among Gram-
positive bacteria [9] including corynebacteria. In fact,
genome sequence analyses of Corynebacterium diphtheriae,
Corynebacterium efficiens, C. glutamicum and Corynebacte-
rium jeikeium revealed that these are the most frequently
used transcriptional regulators in corynebacteria [13].
Examples for functionally characterized members of the
TetR family in C. glutamicum besides AmtR are AcnR,
CGL2612 and McbR. AcnR binds upstream the acn gene
encoding aconitase to the putative consensus sequence
CAGNACnnncGTACTG, which is highly conserved in
corynebacterial and mycobacterial species [14]. CGL2612
is a drug resistance-related regulator with significant struc-
tural similarity to the multidrug resistance-related tran-
scription factor QacR from Staphylococcus aureus [15].
McbR binds to the consensus motif TAGAC-N6-GTCTA
and is involved in the regulation of sulphur metabolism
and the synthesis of sulphur-containing amino acids
[16,17].
Compared to the other TetR-family members in C.
glutamicum, AcnR [14] and CGL2612 [15], the AmtR reg-
ulon is relatively big and compared to especially McbR
[17], the binding consensus is not very strictly conserved.
This raises the questions about the similarities and differ-
ences in protein-DNA recognition, especially in respect to
the well-investigated E. coli TetR. For the AmtR protein-
DNA interface, mutagenesis revealed an important role
for Thr42, Gln53, Ser55, Tyr57, Tyr58, and His59. These
residues are either strictly conserved or there are only very
conservative replacements observed between AmtR and
TetR (Table 1). This finding is consistent with the fact that
both repressors recognize the identical "CTAT"-motif in
the DNA.
For the remaining three residues of the protein-DNA inter-
face (His43, Arg52, Ala54) differences are observed
between AmtR and TetR, which might have implications
Detailed structural analysis of different residues in the DNA  binding domain of AmtR Figure 5
Detailed structural analysis of different residues in 
the DNA binding domain of AmtR. Panels (A) and (B): 
Location and interactions of the non-interface residues that 
were experimentally investigated. Surface-exposed residues 
are depicted as sticks, while those residues that are buried in 
the interior of the protein are shown in space-filled presenta-
tion. Panels (C) to (F): Interactions of the residues located 
in the protein DNA interface. The DNA backbone is shown 
as grey tube and nucleotides of the binding site are shown in 
stick presentation. Contacts are indicated by dotted lines. 
The residues shown in (F) might play a dual role by forming 
both contacts with the DNA and with other parts of the pro-
tein. A water molecule, which was modeled in analogy to the 
TetR-operator complex crystal structure, is shown as green 
ball. See text for more details.BMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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Table 1: Structural features and role for DNA binding of different AmtR residues.
Sequence position Effect on DNA binding Location Structural features Equivalent residue in E. coli TetR
Glu23 o NI solvent exposed, only few interactions Ser8
Glu30 ++ NI Glu30-Arg34 salt bridge Glu15
Leu31 ++ NI buried Leu16
Phe32 +++ NI buried Leu17
Thr33 o NI solvent exposed, only few interactions Asn18
Gly36 o NI C-terminus of helix α1; only few 
interactions
Gly21
Thr40 ++ NI buried Leu25
Thr42 o(+) IF backbone interactions with G3 phosphate 
group
Thr27
His43 + IF G3 ring Arg28
Gly50 ++ NI tight turn Gly35
Ile51 +++ NI buried Ile36
Arg52 + IF backbone contact with T-6 phosphate 
group
Glu37
Gln53 ++ IF side chain contacts with A4 ring Gln38
Ala54 + IF weak non-polar interactions with the 
methyl group of T-6
Pro39
Ser55 ++(+) IF side chain contacts with C-7 Thr40
Leu56 +++ NI buried Leu41
Tyr57 ++(+) IF side chain contacts with A4 and T5 Tyr42
Tyr58 ++(+) IF side chain interactions with DNA and with 
His59
Trp43
His59 +++ IF side chain hydrogen bonds to protein and 
DNA
His44
Leu70 +++ NI buried Leu55
Leu71 ++ NI partially buried Ala56
The first and second column list the residues investigated and their experimentally determined effect on DNA binding. "o" indicates no effect, while 
increasing numbers of "+ signs qualitatively reflect the magnitude, by which DNA binding is decreased. Signs in parenthesis indicate minor 
differences between the two experimental methods used. The third and fourth column list the location of the residue in the structure as deduced 
from the AmtR-DNA model as well as key structural features that might be of relevance for DNA binding. "IF" and "NI" denote protein-DNA 
interface and non-interface residues, respectively. The last column shows the structurally equivalent residues in E. coli TetR.BMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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for binding affinity and specificity. His43 is replaced by
arginine in TetR. This arginine forms specific contacts with
the purine ring of G3 in the TetR-DNA crystal structure
[18]. In the model of the AmtR-DNA complex, the dis-
tance between His43 and the purine ring is larger due to
the shorter histidine side chain, suggesting a weaker inter-
action (Fig. 5C). Although these differences might also
arise from inaccuracies of our model, there are two obser-
vations which suggest a real difference between AmtR and
TetR. First, a replacement of His43 by alanine leads only
to a minor decrease of binding affinity (Fig. 2, 3). Second,
the respective G-C base pair does not represent a part of
the "CTAT" core motif in AmtR (Fig. 4B) and is non-con-
served in AmtR binding sequences [7], while it is con-
served in the "CTATC"-motif recognized by TetR. Arg52 of
AmtR is replaced by glutamic acid in TetR. The presence of
the non-conservative replacement together with the
observation that an arginine to alanine replacement has
only little effect on AmtR binding affinity suggest that the
Arg52 side chain does not play a major role for the DNA
interaction.
Another difference is observed at position 54: The respec-
tive alanine of AmtR is equivalent to Pro39 of TetR. Ala 54
forms interactions with the methyl group of T-6. These
interactions, however, seem only to play a minor role for
the affinity and specificity of DNA recognition. This is evi-
denced by the observation that a replacement by glycine
has only small effects on binding affinity. In addition, the
contact to the methyl-group of base T-6  seems not to
mediate a specific recognition since a replacement of thy-
midine by guanosine still allows an interaction (Fig. 5D,
Fig. 6). In contrast, Pro39 of TetR contacts two thymidines
of adjacent base pairs (T5 and T-6 according to the amtR
nomenclature; Fig. 4B) and a replacement by glutamate
was shown to have a significant effect on binding affinity
and specificity [19]. These findings suggest that Ala54 of
AmtR has a smaller role than Pro39 in TetR for promoter
recognition.
In summary, at least the differences at sequence positions
43 and 54 might explain the larger sequence variability of
DNA recognition by AmtR compared to TetR. Although
AmtR tolerates a certain amount of variability within the
DNA half-sites, their correct spacing appears to be crucial
for binding. The "CTAT" half-sites are separated by a five-
residue spacer in TetR, but by six residues in AmtR. As
demonstrated by the experiment in Fig. 6, this spacing is
essential for the AmtR-DNA interaction. Due to the differ-
ences of the spacer length between TetR and AmtR, the
structural consequences of this feature on the orientation
of the binding heads or the curvature of the DNA cannot
be deduced from the present model, but have to await the
elucidation of a crystal structure of AmtR in complex with
DNA. Future work will now concentrate on the crystalliza-
tion of AmtR without and together with bound DNA.
Using DNA fragments with alterations of the consensus
motif and the kind and number of spacing nucleotides,
this approach will allow to study functional and structural
flexibility of DNA binding domains. Furthermore, the co-
crystallization of AmtR with signal transduction protein
GlnK will provide the first structural information about an
asymmetric GlnK interaction complex. Today, besides the
interaction with AmtR, which most likely acts as a dimer
[5], exclusively interactions with threefold symmetry were
reported, e.g. of the trimeric GlnK complex with trimeric
ammonium transporter AmtB, or with the hexameric key
enzyme for arginine biosynthesis NAGK [20].
Conclusion
Molecular biology and biochemistry approaches such as
site-directed mutagenesis, gel retardation assays and SPR
are, especially in combination with molecular modelling,
powerful tools to identify crucial amino acids for DNA
binding. In this study, we could show that besides by dis-
tinct amino acids of the TetR family protein AmtR, DNA
binding is influenced by nucleotides not only of the con-
served binding motif but also by spacing nucleotides in C.
glutamicum.
Methods
Bacterial strains and growth
C. glutamicum wild type ATCC 13032 [21] was grown at
30°C in MOPS-buffered minimal medium with glucose
as carbon source as described [22].
Gelretardation assays using amtR upstream DNA variants Figure 6
Gelretardation assays using amtR upstream DNA 
variants. (1–3) 0.04 ng of native DNA, (4–6) amtR upstream 
DNA carrying a G to T exchange at position 2, (7–9) amtR 
upstream DNA with additional spacing nucleotide. (1, 4, 7) 
without AmtR-MBP, (2, 5, 8) with 150, (3, 6, 9) with 300 ng 
of AmtR-MBP.BMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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Table 2: Oligonucleotides used in this study.
Designation Sequence (5' → 3') Application
amtRw/oATG-BamHI-fw GGTCGGATCCGCAGGAGCAGTGGG Cloning of amtR into pMalc2
amtR-PstI-rev GGCGCCTGCAGTTATTTCGCGTCAGCCTGC Cloning of amtR into pMalc2
amtR23-fwd TCCTCGCGAGGCGATTCTTGACG Mutagenesis of amtR
amtR25-fwd CGAGGAGATTGCTGACGCCTCTG Mutagenesis of amtR
amtR30-fwd CGCCTCTGCTGCGCTTTTCACCC Mutagenesis of amtR
amtR31-fwd CTCTGCTGAGGCTTTCACCCGTC Mutagenesis of amtR
amtR32-fwd TGCTGAGCTTGCCACCCGTCAAG Mutagenesis of amtR
amtR33-fwd TGAGCTTTTCGCCCGTCAAGGCT Mutagenesis of amtR
amtR36-fwd CACCCGTCAAGCCTTCGCAACAA Mutagenesis of amtR
amtR40-fwd CTTCGCAACAGCCTCCACGCATC Mutagenesis of amtR
amtR42-fwd AACAACCTCCGCGCATCAAATCG Mutagenesis of amtR
amtRH43A CAACCTCCACGGCTCAAATCGCTG Mutagenesis of amtR
amtR50-fwd TGATGCCGTGGCAATCCGCCAAG Mutagenesis of amtR
amtR51-fwd TGCCGTGGGAGCCCGCCAAGCCT Mutagenesis of amtR
amtR52-fwd CGTGGGAATCGCCCAAGCCTCGC Mutagenesis of amtR
amtR53-fwd GGGAATCCGCGCAGCCTCGCTCT Mutagenesis of amtR
amtRA54A GAATCCGCCAAGGCTCGCTGTATTATC Mutagenesis of amtR
amtR55-fwd CCGCCAAGCCGCGCTGTATTATC Mutagenesis of amtR
amtR56-fwd CCAAGCCTCGGCGTATTATCACT Mutagenesis of amtR
amtR57-fwd AGCCTCGCTGGCTTATCACTTCC Mutagenesis of amtR
amtR58-fwd CTCGCTGTATGCTCACTTCCCGT Mutagenesis of amtR
amtR59-fwd GCTGTATTATGCCTTCCCGTCCA Mutagenesis of amtR
amtR63-fwd CTTCCCGTCCGCGACGGAAATCT Mutagenesis of amtR
amtR70-fwd CTTCCTCACCGCGCTGAAATCTA Mutagenesis of amtR
probe-amtB-fw GCT GGG CTA GAA ACC CGA amtB promoter fragment for gel retardation assays 
(nt position -298 to -1)
probe-amtB-rev GCG TGG ATG ACC TCC TTT G amtB promoter fragment for gel retardation assays 
(nt position -298 to -1)
binding1_amtB-fw TAAATTACCTGTTAAACTATAGAAAATATC amtB promoter fragment for SPR (nt position -186 to -156)BMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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General molecular biology techniques
For plasmid isolation, transformation, and cloning stand-
ard techniques were used [23]. E. coli strain DH5α mcr
[24] was used as cloning host.
Site directed mutagenesis
For expression and purification of AmtR variants, point
mutations were inserted into amtR via two-step-PCR using
the oligonucleotides amtR-PstI-rev, amtRw/oATG-
BamHI-fw and mutagenesis primers (Table 2). For ampli-
fication C. glutamicum ATCC13032 cell were used as a
template. In the first step the mutagenesis primer was used
as a forward primer, with amtR-PstI-rev as reverse primer.
After denaturation at 96°C for 30 sec the primers were
aligned at 65°C for 30 sec and elongation was performed
at 72°C for 30 sec. The cycle was repeated 30 times. The
resulting fragment served as a reverse primer in the second
step, with amtRw/oATG-BamHI-fw as forward primer.
Here 58°C was used as annealing temperature and elon-
gation was carried out for 45 sec. The resulting fragment
was cloned into the vector pMalc2 via the restriction sites
BamHI and PstI. All plasmids constructed (Table 3) were
sequenced for control.
Protein purification
E. coli BL21 [25] freshly transformed with pMalc2amtR*
vectors was used for inoculation of 300 ml LB containing
2% glucose. Bacteria were grown over night at 37°C and
used to inoculate 800 ml fresh LB containing 2% glucose
at an OD600 of 0.1. The culture was grown to an OD600 of
0.5 and subsequently induced with 0.3 mM IPTG. After 4
h of incubation the cells were harvested (3,000 × g, 10
min, 4°C) and the pellet was resuspended in 25 ml puri-
fication buffer (20 mM Tris-HCl, pH 7.4, 200 mM NaCl,
1 mM EDTA). The solution was sonicated three times for
30 sec at 70% (Bandelin Sonoplus UW2070, Berlin) and
centrifugated for 10 min with 14,000 × g at 4°C. The
supernatant was loaded onto a 1 ml MBP-Trap column
(GE Healthcare, Munich), washed with 10 column vol-
umes purification buffer and protein bound was eluted
with 20 mM maltose in purification buffer.
Gel retardation experiments
Target DNA for gel shift assays was synthesized by PCR
(for the primers used, see Table 2) and was purified by
agarose gel electrophoresis. To label the DNA and to pre-
pare the reaction mixture for the gel shift assay, the DIG
gel shift kit (Roche, Mannheim) was used as recom-
mended by the supplier. Separation by gel electrophoresis
was performed in native 6% polyacrylamide gels
(Anamed Electrophorese GmbH, Darmstadt, Germany)
using 0.5 × Tris-borate-EDTA buffer as the running buffer.
Subsequently, the labelled DNA was transferred to a
nylon membrane (Roche, Mannheim, Germany) by elec-
tro blotting as described in the protocol of the DIG gel
shift kit (Roche, Mannheim, Germany). For detection of
the labelled DNA, X-ray film was used.
Preparation of amtBp DNA for SPR
Thirty nucleotide synthetic oligonucleotides containing
amtBp  (forward: 5'TAAATTA CCTGTTAAACTAT-
GAAAATATC; backward: 5'-GATATTTTCTATAGTT-
TAACAGG TAATTTA-3') or a nonspecific DNA sequence
(5'CGCGATAATCTTTGCTAACCCTTT TGAGTT-3'; back-
ward: 5'-AACTCAAAAGGGTTAGCAAAGATTATCGCG-3')
were hybridized and used for analyses without further
purification. The forward 30-nt oligonucleotides carried a
biotin at the 3'-end. All oligonucleotides were purchased
with or without modification from MWG Biotech (Ebers-
berg, Germany). The concentration of the hybridized
DNA was determined using a pEQlab (Erlangen) Nano-
drop Spectrophotometer.
Surface plasmon resonance (SPR)
SPR measurements with AmtR from C. glutamicum, over-
expressed as maltose binding protein fusion in E. coli
BL21, were performed using a BIAcoreX instrument oper-
ated at 25°C (Biacore, Uppsala, Sweden). For interaction
analyses of an amtB promoter fragment with AmtR and
AmtR variants 3'end biotinylated DNA comprising amtBp
DNA sequence or a non-specific DNA sequence was
immobilized on the surface of Biacore CM5 chips. For this
purpose, the chip surface was activated with 35 μl of a
mixture of 50 mM N-hydroxysuccinimide and 20 mM N-
bind1_amtB-rew-2 GATATTTTCTATAGTTTAACAGGTAATTTA amtB promoter fragment for SPR (nt position -186 to -156)
amtRbs-f GCCCGTGGTGTGCTCACCAATG amtR promoter fragment for gel retardation assays 
(nt position -291 to -63)
amtRbs-r CAGAGTTCCTATTTGGTATCGATTTCACGGGC amtR promoter fragment for gel retardation assays 
(nt position -291 to -63)
amtRbsG-T-r CAGAGTTCCTATTTGGTATAGATTTCACGGGC amtR promoter fragment for gel retardation assays
amtRbs+N-r CAGAGTTCCTATTATGGTATCGATTTCACGGGC amtR promoter fragment for gel retardation assays
Table 2: Oligonucleotides used in this study. (Continued)BMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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Table 3: Plasmids used in this study
Plasmid Genotype/Description Reference
pMalc2 ptac, ApR, ori ColE1, malE, lacZα, lacIq, E. coli-Vektor for protein purification NEB, Schwalbach
pMalc2amtR pMalc2, ptac-malE-amtR This work
pMalc2amtR *Glu23Ala pMalc2amtR, point mutation in amtR for AmtR*Glu23Ala variant This work
pMalc2amtR* Arg52Ala pMalc2amtR, point mutation in amtR for AmtR*Arg52Ala variant This work
pMalc2amtR* Gly50Ala pMalc2amtR, point mutation in amtR for AmtR*Gly50Ala variant This work
pMalc2amtR* Ile51Ala pMalc2amtR, point mutation in amtR for AmtR*Ile51Ala variant This work
pMalc2amtR* Thr40Ala pMalc2amtR, point mutation in amtR for AmtR*Thr40Ala variant This work
pMalc2amtR* Thr42Ala pMalc2amtR, point mutation in amtR for AmtR*Thr42Ala variant This work
pMalc2amtR*Glu30Ala pMalc2amtR, point mutation in amtR for AmtR*Glu30Ala variant This work
pMalc2amtR*Gly36Ala pMalc2amtR, point mutation in amtR for AmtR*Gly36Ala variant This work
pMalc2amtR*Leu31Ala pMalc2amtR, point mutation in amtR for AmtR*Leu31Ala variant This work
pMalc2amtR*Phe32Ala pMalc2amtR, point mutation in amtR for AmtR*Phe32Ala variant This work
pMalc2amtR*Thr33Ala pMalc2amtR, point mutation in amtR for AmtR*Thr33Ala variant This work
pMalc2amtRAla54Gly pMalc2amtR, point mutation in amtR for AmtR*Ala54Gly variant This work
pMalc2amtRHis43Ala pMalc2amtR, point mutation in amtR for AmtR*His43Ala variant This work
pMalc2amtR*Gly36Ala pMalc2amtR, point mutation in amtR for AmtR*Gly36Ala variant This work
pMalc2amtR*Thr40Ala pMalc2amtR, point mutation in amtR for AmtR*Thr40Ala variant This work
pMalc2amtR*Thr42Ala pMalc2amtR, point mutation in amtR for AmtR*Thr42Ala variant This work
pMalc2amtR*Gly50Ala pMalc2amtR, point mutation in amtR for AmtR*Gly50Ala variant This work
pMalc2amtR*Ile51Ala pMalc2amtR, point mutation in amtR for AmtR*Ile51Ala variant This work
pMalc2amtR*Arg52Ala pMalc2amtR, point mutation in amtR for AmtR*Arg52Ala variant This work
pMalc2amtR*Gln53Ala pMalc2amtR, point mutation in amtR for AmtR*Glu53Ala variant This work
pMalc2amtR*Ser55Ala pMalc2amtR, point mutation in amtR for AmtR*Ser55Ala variant This work
pMalc2amtR*Leu56Ala pMalc2amtR, point mutation in amtR for AmtR*Leu56Ala variant This work
pMalc2amtR*Tyr57Ala pMalc2amtR, point mutation in amtR for AmtR*Tyr57Ala variant This work
pMalc2amtR*Tyr58Ala pMalc2amtR, point mutation in amtR for AmtR*Tyr58Ala variant This work
pMalc2amtR*His59Ala pMalc2amtR, point mutation in amtR for AmtR*His59Ala variant This work
pMalc2amtR*Leu70Ala pMalc2amtR, point mutation in amtR for AmtR*Leu70Ala variant This work
pMalc2amtR*Leu71Ala pMalc2amtR, point mutation in amtR for AmtR*Leu71Ala variant This workBMC Molecular Biology 2009, 10:73 http://www.biomedcentral.com/1471-2199/10/73
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ethyl-N-(3-dimethylaminopropyl)-carbodiimide-hydro-
chloride (Biacore, Uppsala, Schweden). After coupling of
3,000 RU neutravidine (5 μM in 10 mM Na-acetate, pH
5.0), to the chip, 35 μl 1 M ethanolamine (Biacore, Upp-
sala, Sweden) was used to inactivate the remaining reac-
tive carboxyl groups on the chip. Hybridized non-specific
DNA was coupled in flow cell 1 and amtBp DNA in flow
cell 2. In all measurements HBS-EP was used as a running
buffer. The flow rate was 5 μl/min during coupling and 40
μl/min for all measurements. To regenerate the chip sur-
face the dissociation of the amtBP-AmtR or amtBP-AmtR*
variants complex was stopped by injection of 80 μl HBS-
EP buffer at 40 μl/min after each injection. AmtR*-MBP
variant concentrations of 2170 nM, 10870 nM, 28260 nM
and 43470 nM were used. Additionally 43 nM and 870
nM of AmtR were used for the SPR measurements. Evalu-
ation of the data was performed using BiaEvaluation 4.0
Software (Biacore, Uppsala, Schweden). The titrations for
the kinetic measurements have been carried out twice for
each AmtR variant.
Model building
The structure of AmtR from C. glutamicum in complex
with DNA was modeled based on the crystal structure of
the TetR repressor/operator complex from E. coli (PDB
code: 1QPI) [18]. Both proteins share a sequence identity
of 37% in the DNA binding domain, which is also
reflected in the significant E-value of 10-5 for the respective
sequence alignment. Since the remaining parts of the two
repressors are highly divergent in sequence, modeling was
restricted to the DNA binding domain. The two DNA
binding heads of dimeric AmtR were modeled separately
using Swiss-Model [26] and the structure of the protein
DNA complex was obtained by assuming an identical
interface geometry as in the TetR-DNA complex.
The model was subsequently refined by 100 steps of
energy minimization using the Sybyl 7.3 program package
(Tripos Inc.). The quality of the structure was assessed
using Procheck [27] and Whatcheck [28] and did not
reveal any steric clashes or unfavorable geometries thus
confirming the overall good quality of the model. Finally,
contacts between the AmtR and its target DNA were
retrieved using LIGPLOT [29]. Visualization and analysis
of the model features were carried out using the program
Discovery Studio Visualizer (Accelrys Software Inc.).
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